Immuno-Oncology Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Deck Bio on Solid Tumor Immunotherapy, Talent and Biotech Infrastructure

Standardizing Immune-Related AE Management in Global Oncology Trials

August 04, 2026

Calidi Biotherapeutics on Advancing Systemic Virotherapy for Metastatic Cancer

International Childhood Cancer Day 2026: Advances in Pediatric Oncology Research and Care

February 2, 2026

Five-Year Follow-Up Data Released for mRNA Cancer Vaccine in Melanoma

January 23, 2026

Trials for Myelodysplastic Syndrome: Genomics, Immunotherapy and Patient-Centric Design

November 17, 2025

Keytruda Qlex Wins FDA Approval, Enabling One- to Two-Minute Pembrolizumab Delivery

October 16, 2025

Clinical Signals and Strategic Shifts: Insights That Shape Oncology Drug Development

November 20, 2025

Advanced In Vivo Efficacy Models for Preclinical Success

August 26, 2025

Transforming Immuno-Oncology: A Novel Approach to Targeting the Tumor Microenvironment

Vepdegestrant Hits Primary Endpoint in Phase III Breast Cancer Trial

Clinical Trial News

Imlunestrant Delivers Promise as a Monotherapy, Even Stronger Combined with Abemaciclib

December 16, 2024

Blenrep Combination Extends Survival in Relapsed Multiple Myeloma

December 13, 2024

Life Science Podcast

Immune-Based Intratumoral Cancer Therapies ft. Intensity Therapeutics Founder and CEO Lewis Bender

December 13, 2024

Poseida Joins Roche in $1.5B Deal to Deliver Next-Gen CAR-T Therapies

November 29, 2024

Life Science Podcast

Innovating Immunotherapeutics with Oncolytic Virus Therapy ft. Oncolytics Biotech’s CMO Dr. Thomas Heineman

November 27, 2024

Next Page »